Dialyze Direct acquires Renew Dialysis from Saber Healthcare
Home haemodialysis provider Dialyze Direct has announced the acquisition of Renew Dialysis, a regional provider of on-site dialysis services in skilled nursing facilities (SNFs),...
GIRFT report represents “call to action” and provides renewed focus for improving UK kidney...
The Getting It Right First Time (GIRFT) national report on renal medicine represents a “call to action” for the UK renal community, and provides...
Standard vaccination regimens may not provide adequate protection against new SARS-CoV-2 variants for kidney...
Kidney transplant recipients tend to mount impaired antibody responses against emerging SARS-CoV-2 variants after standard two-dose COVID-19 vaccination, according to a study published in the...
Hansa Biopharma enrols first patient in US pivotal trial of kidney transplant desensitisation drug
Hansa Biopharma recently announced that the first patient has been enrolled in its CONFIDES trial—a US pivotal, open-label, randomised controlled study—at the Columbia University Medical Center...
